Iterum Therapeutics Income Statement (2017-2022) | ITRM

Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022
Revenue & cost
Revenue 0.16M0.35M0.19M0.18M0.25M0.24M0.04M
Operating items
Research & Development 5.29M7.43M8.24M10.88M13.72M22.58M21.46M17.39M24.44M28.07M20.88M9.74M5.04M3.94M2.35M2.45M2.71M1.84M3.70M3.44M3.98M4.35M5.84M
Selling, General & Administrative 1.12M1.02M1.31M1.51M1.89M2.66M2.72M3.12M2.94M2.93M2.30M3.15M3.21M2.40M2.29M3.40M4.27M3.03M3.13M3.93M4.07M2.68M2.09M
Other Operating Expenses 0.00M
Operating Expenses 6.41M8.46M9.55M12.39M15.61M25.24M24.18M20.50M27.38M31.00M23.18M12.89M8.25M6.33M4.64M5.85M6.99M4.87M6.83M7.37M8.05M7.03M7.93M
Operating Income -6.41M-8.30M-9.20M-12.20M-15.43M-24.99M-23.94M-20.47M-27.38M-31.00M-23.18M-12.89M-8.25M-6.33M-4.64M-5.85M-6.99M-4.87M-6.83M-7.37M-8.05M-7.03M-7.93M
EBIT -6.41M-8.30M-9.20M-12.20M-15.43M-24.99M-23.94M-20.47M-27.38M-31.00M-23.18M-12.89M-8.25M-6.33M-4.64M-5.85M-6.99M-4.87M-6.83M-7.37M-8.05M-7.03M-7.93M
Non-operating items
Interest & Investment Income 0.05M0.12M0.11M0.09M-0.08M-0.14M-0.33M-0.10M-0.14M-0.22M-0.41M-2.60M-4.08M-4.18M-4.24M-2.95M-0.98M-0.85M-0.77M-1.04M-0.77M-0.64M0.08M
Other Non Operating Income 0.17M0.09M0.03M0.06M-0.18M0.33M0.22M0.12M0.03M0.05M-0.01M1.68M-0.01M-0.64M-2.77M-90.10M15.79M9.78M3.56M5.18M2.15M-4.83M2.96M
Non Operating Income 0.21M0.21M0.14M0.15M-0.25M0.33M0.22M0.12M-0.10M-0.17M-0.41M-3.08M-4.09M-5.44M-6.52M-93.01M14.91M8.97M2.82M4.30M1.66M-22.64M2.94M
Net income details
EBT -6.20M-8.08M-9.07M-12.06M-15.68M-24.80M-24.05M-20.45M-27.48M-31.17M-24.08M-15.98M-12.34M-11.78M-11.86M-98.86M7.92M4.09M-4.01M-3.07M-6.39M-29.68M-4.99M
Tax Provisions 0.08M0.09M0.05M0.09M0.07M0.11M0.21M0.13M0.16M0.10M0.05M0.12M0.18M0.42M0.02M0.06M0.12M0.35M0.17M0.43M0.34M-0.57M0.10M
Profit After Tax -6.28M-8.17M-9.12M-12.15M-15.75M-24.91M-24.26M-20.58M-27.64M-31.27M-23.64M-16.10M-12.52M-12.20M-11.19M-98.92M7.80M3.74M-4.18M-3.50M-6.74M-29.11M-5.09M
Income from Continuing Operations -6.28M-8.17M-9.12M-12.15M-15.75M-24.91M-24.26M-20.58M-27.64M-31.27M-24.12M-16.10M-12.52M-12.20M-11.88M-98.92M7.80M3.74M-4.18M-3.50M-6.74M-29.11M-5.09M
Consolidated Net Income -6.28M-8.17M-9.12M-12.15M-15.75M-24.91M-24.26M-20.58M-27.64M-31.27M-24.12M-16.10M-12.52M-12.20M-11.88M-98.92M7.80M3.74M-4.18M-3.50M-6.74M-29.11M-5.09M
Income towards Parent Company -6.28M-8.17M-9.12M-12.15M-15.75M-24.91M-24.26M-20.58M-27.64M-31.27M-24.12M-16.10M-12.52M-12.20M-11.88M-98.92M7.80M3.74M-4.18M-3.50M-6.74M-29.11M-5.09M
Net Income towards Common Stockholders -6.28M-8.17M-9.12M-12.15M-15.75M-24.91M-24.26M-20.58M-27.64M-31.27M-23.64M-16.10M-12.52M-12.20M-11.19M-98.92M7.80M3.74M-4.18M-3.50M-6.74M-29.11M-5.09M
Additional items
EPS (Basic) -39.44-44.16-43.42-61.36-2.22-1.77-2.78-1.44-1.93-2.15-1.63-1.08-0.80-0.60-6.99-0.810.040.31-0.01-0.29-0.55-2.38-0.41
EPS (Weighted Average and Diluted) -0.80-0.60-30.100.040.28-0.01-0.29-0.55-2.38-0.41
Shares Outstanding (Weighted Average) 0.16M0.19M0.17M0.20M7.09M14.03M8.73M14.29M14.34M14.57M14.52M14.87M15.61M20.39M1.60M121.55M180.02M12.18M10.89M12.19M12.22M12.23M
Shares Outstanding (Diluted Average) 15.61M20.39M1.60M204.60M13.48M10.89M12.19M12.22M12.23M
EBITDA -6.41M-8.30M-9.20M-12.20M-15.43M-24.99M-23.94M-20.47M-27.38M-31.00M-23.18M-12.89M-8.25M-6.33M-4.64M-5.85M-6.99M-4.87M-6.83M-7.37M-8.05M-7.03M-7.93M
Tax Rate -1.26%-1.09%-0.56%-0.74%-0.43%-0.44%-0.86%-0.66%-0.57%-0.33%-0.20%-0.76%-1.44%-3.57%-0.20%-0.06%1.54%8.60%-4.26%-13.90%-5.37%1.92%-2.02%